The Ultimate Fighting Championship signed a deal with the United States Anti-Doping Agency (USADA) to help clean the sport of mixed martial arts and rid the octagon of performance enhancing drugs. Fighters who are on the active UFC roster are subjected to random drug tests, and George Sullivan has been flagged for another potential drug test violation.
Sullivan was expected to return from the current suspension he is serving to compete at “UFC 208” in Brooklyn, New York against Randy Brown, but he has since been pulled from the card due to the violation. UFC released the following statement here which you can read below:
“The UFC organization was formally notified today that the U.S. Anti-Doping Agency (USADA) has informed George Sullivan of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection taken on January 14, 2017.
Sullivan is currently serving a one year suspension under the UFC Anti-Doping Program, for his use of a product containing the prohibited substance Insulin Growth Factor -1 (IGF-1). Sullivan was due to end his current suspension on January 31, 2017, and compete on the UFC 208 card in Brooklyn, New York, against Randy Brown. However, USADA has provisionally suspended Sullivan based on the new potential anti-doping violation, and the UFC has removed Sullivan from the UFC 208 card. The UFC is currently seeking a replacement to face Randy Brown.
USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed.
Consistent with all previous potential anti-doping violations, additional information or UFC statements will be provided at the appropriate time as the process moves forward.”
